Available at: (Accessed: 27 February 2026) [3] Research And Markets, (2024), Global GLP-1 Receptor Agonist (Ozempic, Rybelsus, Trulicity, Saxenda, Wegovy, Victoza, Mounjaro, Zepbound) Market Analysis Report 2024-2030 Featuring Eli Lilly And C, Continue reading GLP-1 agonists have not been in the public sphere for very long, meaning that understanding of long-term side effects is limited
Molecules 2019,24, 4132
J., Lin, S., Xu, W., & Cheung, P
An analysis of the FDA Adverse Event Reporting System (collecting worldwide adverse events) identified an increased reporting odds ratio for alopecia with semaglutide and tirzepatide, while no significant increase was observed for liraglutide, dulaglutide, exenatide, or lixisenatide [81]
Follow these tips to maximize the effectiveness of semaglutide: Medication adherence Take the dosage of semaglutide exactly as prescribed by your healthcare provider to achieve maximum results